Trial intelligence / Profile preview

CHF 1521 vs losartan + hydrochlorothiazide in type 2 diabetic patients with hypertension

2004-001252-36Phase 3Completed

Sponsor
Chiesi Farmaceutici S.p.A.
Start
Sep 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of manidipine + delapril in hypertension (HTN) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Started Sep 2004; status: completed.

02

Drugs

manidipine + delapril
03

Conditions

hypertension (HTN)type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2004-001252-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-001252-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call